Donald R. Proctor
Direktor/Vorstandsmitglied bei The Leukemia & Lymphoma Society, Inc.
Profil
Donald R.
Proctor is currently a Director at The Leukemia & Lymphoma Society, Inc. Prior to this, he was a Senior Vice President at Cisco Systems, Inc. from 2012 to 2016.
He received his undergraduate degree from the University of California, Berkeley.
Aktive Positionen von Donald R. Proctor
| Unternehmen | Position | Beginn |
|---|---|---|
The Leukemia & Lymphoma Society, Inc.
 The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Donald R. Proctor
| Unternehmen | Position | Ende |
|---|---|---|
| CISCO SYSTEMS, INC. | Corporate Officer/Principal | 01.10.2016 |
Ausbildung von Donald R. Proctor
| University of California, Berkeley | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CISCO SYSTEMS, INC. | Technology Services |
| Private Unternehmen | 1 |
|---|---|
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |
